BioAge Labs, Inc.
BIOA
$18.19
$0.030.17%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -72.13% | -22.78% | 13.82% | -58.77% | 0.49% |
| Total Depreciation and Amortization | 70.27% | 46.81% | 28.95% | 18.37% | 12.12% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 35.23% | -42.46% | 29.18% | 96.86% | 54.00% |
| Change in Net Operating Assets | 20.42% | -127.51% | -80.31% | 54.61% | -60.26% |
| Cash from Operations | -38.49% | -449.84% | -7.45% | -26.54% | -10.79% |
| Capital Expenditure | 93.90% | -330.77% | 92.79% | -354.29% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 39.76% | -- | -- | -- | -- |
| Cash from Investing | 40.05% | -55,392.31% | 4,310.16% | -44,588.57% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Issuance of Common Stock | -- | -35.36% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 71.38% | 97.80% | -- | -- |
| Cash from Financing | 8,347.67% | -35.70% | -100.81% | 37.16% | -100.89% |
| Foreign Exchange rate Adjustments | -125.00% | -113.87% | 82.76% | -170.59% | -163.16% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 154.60% | -234.26% | -102.71% | -103.93% | -163.58% |